Transfusion-transmitted HBV infection with isolated anti-HBs-positive blood

被引：7
|
作者：
Satake, Masahiro [1 ]
Yamagishi, Naoji [1 ]
Tanaka, Ami [1 ]
Goto, Naoko [2 ]
Sakamoto, Tomohiko [3 ]
Yanagino, Yusuke [3 ]
Furuta, Rika A. A. [1 ]
Matsubayashi, Keiji [1 ]
机构：
[1] Japanese Red Cross, Cent Blood Inst, 2-1-67 Tatsumi,Koto Ku, Tokyo 1358521, Japan
[2] Japanese Red Cross, Blood Serv Headquarters, Tokyo, Japan
[3] Sakurabashi Watanabe Hosp, Dept Cardiovasc Surg, Osaka, Japan
来源：
TRANSFUSION | 2023年 / 63卷 / 06期
关键词：
anti-HBc; anti-HBs; NAT; OBI; vaccination; HEPATITIS-B-VIRUS; SURFACE-ANTIGEN; DONORS; ANTIBODIES;
D O I：
10.1111/trf.17390
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BackgroundHepatitis B virus (HBV)-positive individuals with isolated anti-HBs are found among HBV vaccine recipients and healthy blood donors with no vaccination history. HBV infectivity from blood transfusions derived from such individuals remains unclear. Case PresentationA male patient who received transfusion with blood negative for individual donation-NAT, HBsAg and anti-HBc but weakly positive for anti-HBs developed typical transfusion-transmitted (TT)-HBV with anti-HBc response. The responsible blood donor was a frequent repeat donor showing a marked increase in anti-HBs titer without anti-HBc response 84 days after index donation. Test results for his past donations showed transient viremia with very low viral load and fluctuating low-level anti-HBs. The HBV vaccination history of this donor was unknown. DiscussionAnti-HBs and anti-HBc kinetics of the donor suggest a second antibody response to new HBV challenge, representing a vaccine breakthrough case. On the other hand, transient low-level viremia and fluctuating anti-HBs in the test results of past donations suggested chronic occult HBV infection with isolated anti-HBs. ConclusionWhatever the basic infection state, blood donors with isolated weak anti-HBs may include a small population with a risk of causing TT-HBV. Identifying individuals harboring such TT-HBV risk among individuals positive only for anti-HBs is difficult under current screening strategies. Active surveillance for the occurrence of TT-HBV with blood positive only for anti-HBs is necessary.
引用
收藏
页码：1250 / 1254
页数：5
相关论文
共 50 条
  • [41] Marked reduction in the incidence of transfusion-transmitted hepatitis B virus infection after the introduction of antibody to hepatitis B core antigen and individual donation nucleic acid amplification screening in Japan
    Tanaka, Ami
    Yamagishi, Naoji
    Hasegawa, Takashi
    Miyakawa, Keiko
    Goto, Naoko
    Matsubayashi, Keiji
    Satake, Masahiro
    TRANSFUSION, 2023, 63 (11) : 2083 - 2097
  • [42] Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers
    Tsutomu Nishida
    Tokuhiro Matsubara
    Takayuki Yakushijin
    Masami Inada
    Hepatology International, 2019, 13 : 407 - 415
  • [43] Residual risk of transfusion-transmitted hepatitis B virus (TT-HBV) infection by NAT-screened blood components: A review of observed versus modeled infectivity from donors with window period and occult HBV infections
    Lelie, Nico
    Busch, Michael
    Kleinman, Steve
    TRANSFUSION, 2021, 61 (11) : 3190 - 3201
  • [44] Risks and challenges of HIV infection transmitted via blood transfusion
    Scott, Sarah Robbins
    Wu, Zunyou
    BIOSAFETY AND HEALTH, 2019, 1 (03) : 124 - 128
  • [45] Cost projections for implementation of safety interventions to prevent transfusion-transmitted Zika virus infection in the United States
    Ellingson, Katherine D.
    Sapiano, Mathew R. P.
    Haass, Kathryn A.
    Savinkina, Alexandra A.
    Baker, Misha L.
    Henry, Richard A.
    Berger, James J.
    Kuehnert, Matthew J.
    Basavaraju, Sridhar V.
    TRANSFUSION, 2017, 57 : 1625 - 1633
  • [46] Managing the risk of transfusion-transmitted malaria from Australian blood donations: Recommendation of a new screening strategy
    Schenberg, Katia
    Hoad, Veronica C.
    Harley, Robert
    Bentley, Peter
    VOX SANGUINIS, 2024, 119 (09) : 945 - 952
  • [47] Evaluation of serological transfusion-transmitted viral diseases and mutliplex nucleic acid testing in malaysian blood donors
    Yaseen, Saif Ghazi
    Ahmed, S. A.
    Johan, M. F.
    Kiron, R.
    Daher, Aqil Mohammad
    TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (03) : 647 - 651
  • [48] The Prevalence of Transfusion-Transmitted Infections and Nucleic Acid Testing Among Blood Donors in Makkah, Saudi Arabia
    Albshri, Mohammad H.
    Ghoth, Ahmad A.
    Mutwalli, Abdulqader A.
    Alzahrani, Naif S.
    Bahattab, Samer S.
    Hanbali, Bassam A.
    Althaqafi, Mohammed H.
    Alqarni, Abdulaziz M.
    Alsulimani, Mansor M.
    Alzahrani, Naif K.
    Alharbi, Fahad S.
    Alansari, Wafaa H.
    Ekram, Abdulelah A.
    Alghamdi, Ali A.
    Alzahrani, Mansour A.
    CLINICAL LABORATORY, 2024, 70 (11) : 2191 - 2197
  • [49] The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia
    Alaidarous, Mohammed
    Choudhary, Ranjay K.
    Waly, Mohamed I.
    Mir, Shabir
    Bin Dukhyil, Abdulaziz
    Banawas, Saeed S.
    Alshehri, Bader M.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (05) : 702 - 706
  • [50] Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report
    Riveiro-Barciela, Mar
    Sauleda, Silvia
    Quer, Josep
    Salvador, Fernando
    Gregori, Josep
    Piron, Maria
    Rodriguez-Frias, Francisco
    Buti, Maria
    TRANSFUSION, 2017, 57 (02) : 244 - 247
12345